Johnson & Johnson (NYSE:JNJ)’s Spravato is reinforcing investor interest in the broader psychedelics sector as it reported ...
Johnson & Johnson reported first-quarter sales above Wall Street’s expectations and bumped up its outlook for the year, led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results